Details for Patent: 8,093,296
✉ Email this page to a colleague
Which drugs does patent 8,093,296 protect, and when does it expire?
Patent 8,093,296 protects COLCRYS and is included in one NDA.
Summary for Patent: 8,093,296
| Title: | Methods for concomitant administration of colchicine and macrolide antibiotics |
| Abstract: | Methods for concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. |
| Inventor(s): | Davis; Matthew W. (Erwinna, PA) |
| Assignee: | Mutual Pharmaceutical Company, Inc. (Philadelphia, PA) |
| Application Number: | 13/090,697 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,093,296 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 8,093,296
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | COLCRYS | colchicine | TABLET;ORAL | 022352-001 | Jul 29, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING GOUT FLARES | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
